Earnings Summary

Burning Rock Biotech Ltd’s revenue jumped 5.16% since last year same period to $142.52Mn in the Q1 2023. On a quarterly growth basis, Burning Rock Biotech Ltd has generated 0.2% jump in its revenue since last 3-months.

Burning Rock Biotech Ltd’s net profit jumped 29.13% since last year same period to $-185.25Mn in the Q1 2023. On a quarterly growth basis, Burning Rock Biotech Ltd has generated 14.32% jump in its net profits since last 3-months.

Burning Rock Biotech Ltd’s net profit margin jumped 32.6% since last year same period to -129.99% in the Q1 2023. On a quarterly growth basis, Burning Rock Biotech Ltd has generated 14.49% jump in its net profit margins since last 3-months.

Burning Rock Biotech Ltd’s earning per share (EPS) estimates for the current quarter stand at -0.37 - a 84.26% jump from last quarter’s estimates.

Burning Rock Biotech Ltd’s earning per share (EPS) estimates for the current year stand at -0.37.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Burning Rock Biotech Ltd’s return on assets (ROA) stands at -0.32.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Burning Rock Biotech Ltd’s return on equity (ROE) stands at -0.65.